Greffex Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $110K

  • Investors
  • 5

Greffex General Information

Description

Developer of a universal vaccine production platform designed to deliver vaccines in a fast, efficient, and affordable manner. The company offers fully deleted, helper-independent vectors and is an ideal delivery medium for vaccines against infectious diseases, including pandemic influenza strains, anthrax, and dengue fever, enabling healthcare providers to produce effective, cost-efficient, and scalable vaccines with improved durability and easier distribution.

Contact Information

Website
www.greffex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1502 Augusta Drive
  • Suite 120
  • Houston, TX 77057
  • United States
+1 (346)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1502 Augusta Drive
  • Suite 120
  • Houston, TX 77057
  • United States
+1 (346)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Greffex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Mar-2021 $110K Completed Generating Revenue
3. Angel (individual) 11-Aug-2017 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Jul-2008 $1.18M $1.18M Completed Generating Revenue
1. Grant $13.5M Completed Startup
To view Greffex’s complete valuation and funding history, request access »

Greffex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Greffex’s complete cap table history, request access »

Greffex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a universal vaccine production platform designed to deliver vaccines in a fast, efficient, and affordable m
Other Pharmaceuticals and Biotechnology
Houston, TX
13 As of 2026

Newcastle upon Tyne, United Kingdom
 

New Haven, CT
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Greffex Competitors (19)

One of Greffex’s 19 competitors is Alcyomics, a Formerly VC-backed company based in Newcastle upon Tyne, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alcyomics Formerly VC-backed Newcastle upon Tyne, United Kingdom
Artificial Cell Technologies Corporation New Haven, CT
Tanabe Pharma Private Equity-Backed Osaka, Japan
Biosceptre Venture Capital-Backed Cambridge, United Kingdom
aVaxMed Venture Capital-Backed Abingdon, United Kingdom
You’re viewing 5 of 19 competitors. Get the full list »

Greffex Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 39

    Pending

  • Expiring in next 12 mo

Greffex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4294930-A1 Gene therapy for retinal diseases Pending 12-Feb-2021
EP-4294930-A4 Gene therapy for retinal diseases Pending 12-Feb-2021
US-20240102048-A1 Gene therapy for retinal diseases Pending 12-Feb-2021
WO-2022174146-A1 Gene therapy for retinal diseases Inactive 12-Feb-2021
JP-2025098049-A Design of optimized universal influenza vaccines and their designs and uses Pending 18-Nov-2020 A61K39/145
To view Greffex’s complete patent history, request access »

Greffex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Greffex Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Convergence Ventures (Houston) Venture Capital Minority
National Institute of Diabetes and Digestive and Kidney Diseases Government
National Institute of Standards and Technology Government
National Institutes of Allergy and Infectious Disease Government
To view Greffex’s complete investors history, request access »

Ready to get started?

Request a free trial

Greffex FAQs

  • When was Greffex founded?

    Greffex was founded in 1999.

  • Where is Greffex headquartered?

    Greffex is headquartered in Houston, TX.

  • What is the size of Greffex?

    Greffex has 13 total employees.

  • What industry is Greffex in?

    Greffex’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Greffex a private or public company?

    Greffex is a Private company.

  • What is Greffex’s current revenue?

    The current revenue for Greffex is .

  • How much funding has Greffex raised over time?

    Greffex has raised $1.33M.

  • Who are Greffex’s investors?

    National Institutes of Health, Convergence Ventures (Houston), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Standards and Technology, and National Institutes of Allergy and Infectious Disease have invested in Greffex.

  • Who are Greffex’s competitors?

    Alcyomics, Artificial Cell Technologies, Tanabe Pharma, Biosceptre, and aVaxMed are some of the 19 competitors of Greffex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process